Ferrero on April 12 asked U.S. consumers to dispose of some Kinder chocolate products not authorized for distribution in the country, warning they could be from the batch recently recalled in Europe due to a potential Salmonella Typhimurium contamination.
Amidst news of current COVID-19 vaccines proving less effective against infections with Delta and Omicron variants of the disease, researchers are turning toward the development of pan-coronavirus vaccines that would work effectively against multiple variants. Scientists and researchers at the Walter Reed National Military Medical Center (WRNMC) in Maryland have been doing just that over the past two years and announced they are testing the vaccine in humans in a Phase I study.
Shares of Taysha Gene Therapies were down more than 10 percent after a patient’s death marred positive interim data for the company’s experimental gene therapy treatment for Sandhoff and Tay-Sachs diseases, which are two forms of GM2 gangliosidosis.
Pfizer, Moderna shots safe during in vitro fertilization; healthy gut bacteria may help prevent long COVIDBacteria, BNT162b2 (Pfizer and BioNTech), Clinical Trials, COVID-19 cases, COVID-19 Studies, COVID-19 Test Kits, COVID-19 Vaccinations, COVID-19 Vaccines, Covid-19 Variants, Gut microbes, In-Vitro Fertilization, JAMA, Long COVID, Microbiome, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Myocarditis, Portable PCR COVID-19 Test Kits, R&D, SARS-CoV-2 virus, Small Intestine
COVID-19 vaccines using mRNA technology do not affect fertility outcomes during in-vitro fertilization (IVF), researchers found. Other new findings suggest the bacteria living in the small intestine may contribute to the risk for long COVID after infection with SARS-CoV-2.
More than 1.2 million people died in 2019 from infections caused by bacteria resistant to multiple antibiotics, higher than HIV/AIDS or malaria, according to a new report published on January 20.
To alleviate the problem of antibiotic-resistant bacteria, or superbugs, several biotechnology companies are developing different strategies to target and kill these microorganisms.
Shares of Forte Biosciences plunged after announcing that a Phase II atopic dermatitis trial assessing the company’s lead pipeline candidate failed to demonstrate statistical significance in the primary endpoint.
The U.S. Food and Drug Administration approved AbbVie’s Dalvance (dalbavancin) for acute bacterial skin and skin structure infections in pediatric patients as young as newborns.
Data from a mid-stage clinical study of an experimental vaccine candidate developed by Affinivax and Astellas Pharma for Streptococcus pneumoniae shows ASP3772 is well tolerated and generated an antibody response against the deadly bacterial infection.
Jazz Pharmaceuticals won U.S. regulatory approval for a new leukemia drug aimed at patients who have developed hypersensitivity to E. coli-derived asparaginase, an enzyme that is a component of the chemotherapy regimen used to treat acute lymphoblastic leukemia (ALL).